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Abstract
Background: Although Campylobacter jejuni-infections have a high prevalence worldwide and represent a significant
socioeconomic burden, it is still not well understood how C. jejuni causes intestinal inflammation. Detailed investigation of
C. jejuni-mediated intestinal immunopathology is hampered by the lack of appropriate vertebrate models. In particular, mice
display colonization resistance against this pathogen.
Methodology/Principal Findings: To overcome these limitations we developed a novel C. jejuni-infection model using
gnotobiotic mice in which the intestinal flora was eradicated by antibiotic treatment. These animals could then be
permanently associated with a complete human (hfa) or murine (mfa) microbiota. After peroral infection C. jejuni colonized
the gastrointestinal tract of gnotobiotic and hfa mice for six weeks, whereas mfa mice cleared the pathogen within two
days. Strikingly, stable C. jejuni colonization was accompanied by a pro-inflammatory immune response indicated by
increased numbers of T- and B-lymphocytes, regulatory T-cells, neutrophils and apoptotic cells, as well as increased





2/2 mice revealed that TLR4- and TLR9-signaling was essential for immunopathology following C. jejuni-infection.
Interestingly, C. jejuni-mutant strains deficient in formic acid metabolism and perception induced less intestinal
immunopathology compared to the parental strain infection. In summary, the murine gut flora is essential for colonization
resistance against C. jejuni and can be overcome by reconstitution of gnotobiotic mice with human flora. Detection of C.
jejuni-LPS and -CpG-DNA by host TLR4 and TLR9, respectively, plays a key role in immunopathology. Finally, the host
immune response is tightly coupled to bacterial formic acid metabolism and invasion fitness.
Conclusion/Significance: We conclude that gnotobiotic and ‘‘humanized’’ mice represent excellent novel C. jejuni-infection
and -inflammation models and provide deep insights into the immunological and molecular interplays between C. jejuni,
microbiota and innate immunity in human campylobacteriosis.
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Introduction
In industrialized countries Campylobacter jejuni is among the most
frequent causative agents of bacterial enteritis [1]. The Gram-
negative pathogen is transmitted via the food chain from farm
animals to humans by the ingestion of undercooked meat, non-
pasteurized milk, and water [2,3]. After infection C. jejuni colonizes
the human distal small intestine and colon. Clinical symptoms
include abdominal pain, fever, myalgia, and watery or bloody
diarrhea. After active invasion of colonic epithelial cells, C. jejuni
induces mucosal inflammation characterized by neutrophil
infiltration, crypt abscesses, focal ulcerations, and plasma cell
proliferation [4–6]. Although the vast majority of infections are
self-limited, in some cases infection might result in chronic
sequelae such as Reiter’s syndrome, reactive polyarthropathy,
and Guillain-Barre ´ syndrome [2,7].
Whereas colonization factors of C. jejuni are well known [8], the
molecular mechanisms underlying immunopathology of C. jejuni-
infection in the host are still poorly understood. Insights into C.
jejuni - host interactions are limited due to the scarcity of suitable
experimental in vivo models [9]. While chickens are well suited to
investigate colonization, vertebrate models using newborn pigs,
weanling ferrets, gnotobiotic canine pups, and primates have
numerous limitations including high costs, handling issues, and
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20953a lack of reproducibility [9,10]. Mice are highly convenient for the
study of bacterial pathogenicity and can help to overcome several
of these limitations. Murine models of C. jejuni-infection, however,
have the disadvantage of sporadic colonization and/ or absence of
clinical disease manifestations [1]. This is in part due to the
colonization resistance against C. jejuni displayed by conventional
mice with a normal commensal microflora. The use of germfree
animals or mice with a limited gut flora has alleviated these
shortcomings with varying degrees of success [10,11]. It was
demonstrated earlier that C. jejuni colonized the entire gastroin-
testinal (GI) tract of isolator-raised germfree mice and induced
clinical signs of disease including granulocyte infiltrates, bloody
diarrhea, and humoral immune responses, reproducibly occurring
after infection [12–16]. However, germfree mice have an
abnormal development of gut-associated lymphoid tissue [17,18].
Therefore, germfree mice might not represent a suitable
experimental model of C. jejuni-infections in humans due to the
lack of an intact innate immune system. Furthermore, mice
deficient in the central innate immunity adaptor protein MyD88
essential in Toll-like receptor (TLR) signaling were stably
colonized by C. jejuni but did not develop intestinal inflammation
[19]. Interaction of C. jejuni with individual TLRs, namely TLR2,
TLR4, and TLR9 recognizing bacterial lipoproteins (LP),
lipopolysaccharide (LPS), or CpG-DNA, respectively, still await
detailed investigation particularly in vivo and in the intestines in situ.
In many in vitro studies, however, TLR signaling could be
demonstrated to be involved in C. jejuni-induced immune
responses. Whereas C. jejuni bacteria were not recognized by
human TLR5 [20], live and lysed C. jejuni cells activated TLR2,
TLR4 and TLR9 via MyD88 in different human, murine or avian
cell lines [21–25]. The role of TLR9 signaling in human C. jejuni
enteritis is not clear yet. C. jejuni activated avian, but not human
TLR9 transiently expressed in a transfected cancer cell line in vitro
[21]. However, the role of TLR9 in C. jejuni enteritis has not been
investigated in vivo so far. For proper LPS-mediated TLR4
activation, the adapter proteins MyD88 or TRIF are essentially
required [26]. In recent studies, IL-10 deficient mice harboring a
conventional gut flora developed significant signs of intestinal
immunopathology following C. jejuni-infection [27–29]. In addi-
tion, enteritis and bacterial translocation were also observed in
TLR4
2/2 IL-10
2/2 double deficient mice [29]. Taken together,
these results point towards pivotal functions of the host-specific gut
microflora and the innate immune system in both, infection
control and inflammation.
In order to optimize murine models for C. jejuni enteritis
mimicking human immunopathology, we used our gnotobiotic
murine model in which the intestinal flora was completely
eradicated by quintuple antibiotic treatment [30–32]. Then, we
reconstituted these germfree mice with a complete human gut
flora to display the human intestinal environment in mice with a
fully developed immune system. The results obtained with C. jejuni-
infected gnotobiotic or ‘‘humanized’’ mice presented here prove
for the first time that the host specific gut flora plays a crucial role
in colonization resistance against C. jejuni. Furthermore, we
demonstrate that TLR4- and, strikingly, TLR9-mediated signaling
are essentially involved in C. jejuni-induced immunopathology.
Lastly, we show that the host responses to C. jejuni infection are
tighly coupled to the pathogen’s formic acid metabolism and
perception essential for cell invasion fitness by analyzing the
respective deletion mutants in our novel in vivo models. Thus, our
results presented here indicate for the first time that gnotobiotic
mice reconstituted with human gut flora provide deep insights into
the ‘‘me ´nage a ` trois’’ of C. jejuni, human commensal gut flora and
the host innate immune system.
Results
Gnotobiotic mice as a novel model for studying C. jejuni -
host interactions
Given that the commensal murine gut microbiota is essential for
the resistance against C. jejuni colonization and thus suitable mouse
models of C. jejuni-infection are scarce, we established a novel
murine experimental system to investigate the interplay (‘‘me ´nage
a ` trois’’) of the gut microbiota and innate immune system on the
host side with the pathogen after oral C. jejuni-infection and
permanent intestinal colonization. For this purpose, we generated
gnotobiotic mice by quintuple antibiotic treatment for six weeks
(refer to [30]). It was essential to handle these animals under
strictly sterile conditions throughout the entire antibiotic treatment
and experimental procedures in order to prevent from secondary
contaminations. Results from cultural and molecular analyses
confirmed that these gnotobiotic mice were completely free of any
culturable and non-culturable bacteria (Fig. S1). Similar to
isolator-raised germfree animals, the antibiotics-treated mice
developed a mega-cecum that is a characteristic morphologic
indicator for a sterile gut.
We determined the colonization capacity of C. jejuni in
gnotobiotic mice after antibiotic treatment as compared to mice
harboring a conventional gut flora following peroral infection with
the C. jejuni reference strains ATCC 43431 [33,34], 81–176
[35,36] and B2 [37]. These strains originate from humans with
severe enteritis, are invasive in vitro and were extensively
investigated in earlier studies. C. jejuni 81–176 carries a virulence
plasmid that encodes components of a type IV protein secretion
machinery [38].
The results confirmed that conventional mice bred in our SPF
facilities display a strong colonization resistance, as at the time of
necropsy at day (d) 12 post infection (p.i.) C. jejuni irrespective of
the strain used could not be detected in fecal samples in the
majority of the animals (Fig. S2). Kinetic studies revealed that C.
jejuni was expelled from the GI tract already within 48 hours after
infection (data not shown). Strikingly, colonization resistance was
completely abrogated in gnotobiotic mice generated by quintuple
antibiotic treatment as all three C. jejuni strains colonized at high
concentrations of 10
9–10
10 colony forming units (CFU) per gram
fecal sample at day 12 p.i. (Fig. S2).
In addition, C. jejuni densities within the GI tract of gnotobiotic
mice were analyzed in more detail (Fig. 1). Following peroral
infection, C. jejuni ATCC 43431 and 81–176 readily colonized the
stomach, duodenum, ileum and colon at comparable levels with
the highest bacterial loads in the large intestine reaching
.10
9 CFU per gram luminal content at d12 p.i.. Kinetic
experiments revealed that in gnotobiotic animals, C. jejuni
colonization was stable throughout a time period of more than
100 days p.i. (data not shown), indicating that this model is well
suited to examine long-term evolution and host-adaptation of the
pathogen in vivo.
TLR4 and TLR9 play an important role in C. jejuni
immunopathology
In order to investigate the role of TLR4 and TLR9 signaling in
the development of immunopathology after stable C. jejuni
colonization in vivo, we generated gnotobiotic mice deficient in
TLR4, TLR9, MyD88 or TRIF by antibiotic treatment.
At day 12 following peroral infection with C. jejuni ATCC
43431, significant histopathological changes in colon sections of
wildtype (WT) mice such as loss of goblet cells, crypt elongation,
and immune cell infiltration could be observed which were less
pronounced in infected TLR4-deficient mice (Figure S3). In order
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responses in the inflamed colon in situ and to quantitate the degree
of histopathology we performed immunohistochemical stainings of
colon section. Given that apoptosis is commonly used as a
diagnostic marker in the histopathological evaluation and grading
of intestinal diseases, we quantitatively determined apoptotic cells
and, in addition, the influx of neutrophils acting as inflammatory
effector cells within the colon mucosa following C. jejuni-infection.
Twelve days p.i., C. jejuni ATCC 43431 colonization densities were
comparable within the respective segments of the GI tract
(stomach, duodenum, ileum, and colon) irrespective of the
genotype of mice under investigation with highest bacterial counts
in the colon (approximately 10
9 CFU/ g luminal colon content;
data not shown). Gnotobiotic mice deficient in TLR4, TLR9,
TRIF or MyD88, however, displayed significantly less inflamma-
tory responses compared to respective wildtype controls as
indicated by lower numbers of Caspase3
+ apoptotic and MPO7
+
neutrophilic granulocytes in the colon in situ (Fig. 2 A, B).
Furthermore, we observed significantly lower numbers of CD3
+ T-
lymphocytes, FOXP3
+ regulatory T-cells (Tregs), and B220
+ B-





2/2 infected mice compared to WT mice
at d12 p.i. (Fig. 2 C–E). Interestingly, Treg and B-lymphocyte
counts of infected TRIF
2/2 and MyD88
2/2 animals did not
differ when compared to non-infected controls (Fig. 2 D, E). In
addition, B220
+ cells within the colon mucosa of TLR4
2/2 mice
did not increase within 12 days following C. jejuni-infection (Fig. 2
E). These results hightlight the gnotobiotic mouse model following
antibiotic treatment as a well-suited vertebrate model for the study
of C. jejuni colonization and pathogen-host interaction mounting in
immunopathological responses similar to those seen in humans
with Campylobacter enteritis. Strikingly, we demonstrate for the first
time in vivo that MyD88- and TRIF-dependent sensing of
Campylobacter-LPS and -CpG-DNA via TLR4- and TLR9-
signaling is essentially involved in C. jejuni-mediated immunopa-
thology.
Generation of mice reconstituted with a complete
human gut flora
Using our gnotobiotic mouse model we were able to study the
dual interaction between C. jejuni and the murine host. In order to
get deeper insights into the triangle relationship (‘‘me ´nage a ` trois’’)
of the pathogen, the host innate immune system and the human
versus the murine microbiota, we replenished gnotobiotic mice
with a human or murine gut flora by gavage. Quantitative analyses
of the main bacterial communities by culture (Fig. 3 A) and
molecular techniques (Fig. 3 B–C, Fig. S4) revealed that the
human or murine microbiota was effectively and permanently
established within the gut for more than six weeks as indepen-
dently confirmed by PCR-based genetic fingerprinting of fecal
samples (Fig. 3 C). According to the typical differences in the
microbiota composition of the two host species, lactobacilli were
predominantly found in the murine flora associated (mfa) mice
whereas human flora associated (hfa) animals harbored higher
total bacterial and higher individual species loads of enterobacteria
(E. coli), enterococci, Bacteroides/ Prevotella spp., and clostridia as
determined by cultural (Fig. 3 A) and molecular (Fig. 3 B)
Figure 1. C. jejuni colonization along the gastrointestinal tract of gnotobiotic mice. Gnotobiotic mice generated by antibiotic gut
decontamination were orally infected with C. jejuni strains ATCC 43431 (open circles) or 81–176 (closed circles) as described in methods. The
pathogen densities in distinct compartments of the gastrointestinal tract were determined by quantification of live C. jejuni in luminal samples taken
from stomach, duodenum, ileum, and colon at day 12 p.i. by cultural analysis (CFU, colony forming units). Numbers of animals harboring C. jejuni out
of the total number of analyzed animals are given in parentheses. Medians (black bars) are indicated. Data shown were pooled from three
independent experiments.
doi:10.1371/journal.pone.0020953.g001
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molecular six-weeks follow-up revealed that C. jejuni-infected
‘‘humanized’’ mice displayed higher enterobacteria, Bacteroides/
Prevotellaspp. and Clostridium coccoides loads intheir feces ascompared
to mfa animals (Fig. S4 A).
C. jejuni colonization in ‘‘humanized’’ mice
Two weeks following reconstitution of gnotobiotic mice with
human or murine flora (to assure proper establishment of the
microbiota along the GI tract), hfa and mfa mice were perorally
infected with C. jejuni ATCC 43431 (d0). Kinetic analyses of the
pathogen loads were performed in fecal samples and in distinct
compartments of the entire GI tract after necropsy (d12 p.i.).
Results revealed that mfa mice were protected from intestinal
colonization as indicated by effective clearance of C. jejuni from the
GI tract during the first two to three days p.i. (Fig. 4 A). In
‘‘humanized’’ mice, however, C. jejuni ATCC 43431 did stably
colonize (Fig. 4 B) with bacterial loads of up to 10
8 CFU per g
feces. Long-term kinetic experiments in hfa mice revealed that C.
jejuni ATCC 43431 colonization of stomach, ileum, and colon was
stable for more than six weeks p.i. with the highest bacterial loads
in the colon (Fig. 4 C).
C. jejuni-induced intestinal immunopathology in
‘‘humanized’’ mice
In humans, C. jejuni induces the recruitment of pro-inflamma-
tory immune cell populations to sites of inflammation in the colon
[4,5]. Therefore, we investigated apoptotic cell, neutrophil, T- and
B-lymphocyte as well as Treg recruitment in the colonic
mucosa during C. jejuni-infection in both, hfa and mfa mice by
immunohistochemical staining of Caspase-3, MPO7, CD3, B220,
and FOXP3 in colon sections of infected mice, respectively
(Fig. 5). Remarkably, after reconstitution of gnotobiotic mice with
a human or murine gut microbiota no differences were observed in
the numbers of apoptotic cells, neutrophilic granulocytes, T- and
B-lymphocytes or Tregs in the colon mucosa in situ. However,
quantitative analyses of the respective immune cell populations
after C. jejuni ATCC 43431-infection revealed that C. jejuni-
infection induced a pronounced inflammatory response in the
colon of hfa mice (Fig. 5). Twelve days p.i., a five-fold increase in
apoptotic cells within the colon mucosa was observed in hfa mice
as compared to infected mfa and uninfected control animals
(Fig. 5 A). This increase of apoptotic cells was accompanied by a
three-fold increase in neutrophil numbers in the colon mucosa of
C. jejuni-infected hfa mice (Fig. 5 B). Furthermore, higher T- and
B-lymphocyte as well as Treg counts were found in the colon
mucosa at d12 following C. jejuni-infection with significantly higher
T-lymphocyte and Treg numbers in hfa as compared to mfa mice
(Fig. 5 C–E).
Next, we determined secretion of pro-inflammatory cytokines in
the colon of C. jejuni-infected mice. At d12 p.i., hfa mice displayed
higher TNF-a, IL-6 and MCP-1 concentrations in their large
intestine as compared to mfa and uninfected control animals
(Fig. 6 A–C). It is noteworthy that following C. jejuni-infection the
respective means of TNF-a, IL-6, and MCP-1 levels increased by
factors 2, 3, and 5, respectively, as compared to naı ¨ve hfa controls.
The multi-fold increases of secreted pro-inflammatory cytokines,
in the context of significant increases in immune cell numbers in
colons sections of infected hfa mice (Fig. 5), point towards a
biological relevant effect despite the high standard deviations
within the infected hfa groups.
Figure 2. Impact of host bacterial sensing on immunopathology in the colon following C. jejuni-infection. Gnotobiotic wildtype (WT;
C57BL/10 (C10) or C57BL/6 (C6) as indicated), TLR4
2/2 (lower panel), TLR9
2/2, TRIF
2/2, and MyD88
2/2 (upper panel) mice generated by antibiotic
gut decontamination were orally infected with C. jejuni strain ATCC 43431. The average numbers of apoptotic cells (positive for caspase-3, panel A),
neutrophilic granulocytes (neutrophils, positive for MPO-7, panel B), T-lymphocytes (positive for CD3, panel C), regulatory T-cells (Tregs, positive for
FOXP3, panel D) and B-lymphocytes (positive for B220, panel E) from at least six high power fields (HPF, 4006 magnification) per animal were
determined microscopically in immunohistochemically stained colon sections. Numbers of animals of the respective genotype analyzed are given in
parentheses. Means (black bars) and levels of significance (P-values) as compared to the respective infected WT control group (determined by the
Student’s t-test) are indicated. Data shown were pooled from three independent experiments.
doi:10.1371/journal.pone.0020953.g002
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mice are not only susceptible to colonization but also display
typical pro-inflammatory features of human campylobacteriosis.
The role of C. jejuni formic acid metabolism and
perception in inducing immunopathology
We further investigated gnotobiotic and hfa mice as suitable
experimental models for the study of C. jejuni virulence factors in
colonization and immunopathology. For this purpose we per-
formed infection experiments with two different C. jejuni mutant
strains deficient in factors essential for cellular invasion. Both
mutant strains were recently generated by transposon mutagenesis
and displayed a reduced invasion capacity into epithelial cell lines
in vitro [37]. The mutant strains carrying transposon (TnKan)
insertions in the genes for formate dehydrogenase subunit D fdhD
(strain B2DfdhD) or the formic acid receptor Tlp7 (strain
B2Dcj0952c) were generated in the C. jejuni B2 background as
described earlier [37]. The formic acid receptor was shown to be
associated with the cell invasion capacity of C. jejuni [37]. Briefly, if
compared to the parental strain, the B2Dcj0952c mutant displayed
Figure 3. Microflora analysis of gnotobiotic mice with human or murine gut flora. Gnotobiotic mice generated by antibiotic gut
decontamination were recolonized with a human (HFA, H) or murine (MFA, M) microflora as described (see methods). Main gut bacterial groups were
quantified by culture and molecular analysis of fecal samples before and after C. jejuni-infection (d42 p.i.). (A) Culture. Total bacterial counts (TOTAL)
and numbers of E. coli, enterococci (EC), Lactobacilli (Lacto) and Bacteroides/ Prevotella spp. (B/P) were determined in feces samples of MFA (M) and
HFA (H) mice right before C. jejuni-infection (day 0) by detection of colony forming units (CFU) per gram feces on appropriate culture media (see
methods). Bacterial species were identified by biochemical analysis and reconfirmed by comparative sequence analyses of 16S rRNA genes. Numbers
of animals harboring the respective bacterial species are given in parentheses. Medians and significance levels (P-values) determined by Mann-
Whitney-U test are indicated. Data shown were pooled from three independent experiments. (B) RT-PCR analysis of the murine and human
flora. Quantitative Real-Time-PCR amplifying bacterial 16S rRNA variable regions. 16S rRNA gene numbers/ ng DNA from luminal colon content from
hfa (H) or mfa (M) mice after stable re-colonization before C. jejuni-infection (day 0) of the following bacterial groups were determined:
Enterobacteriaceae (EB), Enterococci (EC), Lactic acid bacteria (LB). Bacteroides/Prevotella spp. (BP), Clostridium leptum group (CL), Clostridium coccoides
group (CC), Mouse intestinal bacteroidetes (MIB), Bifidobacteria (BB), and total eubacterial load (TL). Numbers of animals harboring the respective
bacterial rRNA are given in parentheses. Medians and significance levels (P-values) determined by Mann-Whitney-U test are indicated. Data shown
were pooled from three independent experiments. (C) Genetic fingerprinting of the murine and human flora. Molecular fingerprints were
generated by PCR-based DGGE analysis of total DNA isolated from luminal colon contents as described (see methods) of six individual hfa (left panel)
and mfa mice (right panel). Samples were taken after stable recolonization, but before C. jejuni-infection (day 0) and 42 days after infection (day 42
p.i.).
doi:10.1371/journal.pone.0020953.g003
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gentamicin protection assays with Caco-2 cells). To investigate
the role of formate dehydrogenase and the formic acid receptor in
immunopathology we infected hfa mice with the B2DfdhD or
B2Dcj0952c mutant strain (Fig. S5). Control mice were infected
with the parental C. jejuni strain B2. Results indicate that the
invasion capacity and the formic acid metabolism are not required
for intestinal colonization, but play essential roles in C. jejuni-
mediated immunopathology. Both mutant strains colonized hfa
mice similarly at high loads (up to 10
7–10
8 CFU/ g feces) as
compared to the parental B2 strain (Fig. S5 A–C). Immunopa-
thology, however, was exclusively induced by the parental strain,
but not by either mutant (Fig. 7). Numbers of apoptotic cells, T-
lymphocytes and Tregs within the colon mucosa 12 days after
infection with either mutant remained comparable to non-infected
mice, but highly significantly increased multi-fold after oral
infection with the parental strain (Fig. 7 A, C, D). In addition,
the numbers of neutrophils and B-lymphocytes increased in the
Figure 4. C. jejuni colonization in mice with a murine or human gut microbiota. Following oral infection with C. jejuni ATCC 43431, kinetic
analyses of the pathogen loads in feces samples of gnotobiotic mice reconstituted with a murine (A) or human (B) gut flora until d12 p.i. were
performed by culture (as described in methods; CFU, colony forming units). In addition, C. jejuni burdens in distinct compartments of the
gastrointestinal tract (stomach, duodenum, ileum, colon; C) of mfa (M, open circles) and hfa (H, filled circles) mice at d12 p.i. were determined by
quantification of live C. jejuni by culture. Numbers of animals harboring C. jejuni out of the total number of analyzed animals are given in parentheses.
Medians (black bars) and significance levels (P-values, hfa as compared to mfa animals) determined by Mann-Whitney-U test are indicated. Data
shown are representative for three independent experiments.
doi:10.1371/journal.pone.0020953.g004
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non-infected controls (Fig. 7 B, E). However, the MPO7
+ or
B220
+ cell counts were higher in animals infected with the
parental strain as compared to mice infected with either mutant.
Furthermore, lower numbers of in situ immune cell counts were
accompanied by significantly lower IL-6 and IFN-c protein
concentrations in ex vivo colon cultures obtained from mice
infected with the respective mutant as compared to the parental
strain infected controls (at d12 p.i.). In addition, mice infected with
the C. jejuni mutant B2DfdhD displayed lower nitric oxide secretion
in the colon as compared to mice infected with the parental strain
(Fig. 8 A–C).
C. jejuni translocation in gnotobiotic and hfa, but not mfa
mice
Studies have shown that live C. jejuni is able to translocate to the
mesenteric lymph nodes (MLNs) in infected isolator-raised germfree
animals [12–14]. Therefore, we determined the translocation capacity
of the parental strain and both mutants, B2DfdhD and B2Dcj0952c in
vivo. Quantitative cultural analysis of live bacteria in MLNs, spleen,
liver, kidney, and cardiac blood of infected gnotobiotic and hfa mice
revealed that at d12 p.i. C. jejuni translocates to MLNs (Fig. 9)b u tn o t
to other organs or blood (data not shown) in gnotobiotic or hfa mice.
Mfa mice displaying a strong colonization resistance against C. jejuni
served as negative controls. Interestingly, the translocation frequencies
(100% vs. 68%) as well as the bacterial loads (medians of
approximately 10
5 vs. 10
2 CFU/ g organ homogenate) of the C. jejuni
B2 parental strain in MLNs were higher in infected gnotobiotic versus
‘‘humanized’’ animals at day 12 p.i., with no differences as compared
to other C. jejuni strains such as ATCC 43431 and 81–176 (not shown).
In gnotobiotic and hfa mice, both, the C. jejuni B2DfdhD and
B2Dcj0952c mutant strain, translocated less frequently into MLNs as
compared to the parental strain with lower counts of approximately
two orders of magnitude following infection with the B2DfdhD mutant
versus the parental strain (Fig. 9).
Discussion
The commensal intestinal flora constitutes a barrier to
effectively prevent the host from colonization and infection by
Figure 5. Immunopathological responses in the colon of ‘‘humanized’’ mice in situ following C. jejuni-infection. Mfa and hfa mice were
generated and orally infected with C. jejuni strain ATCC 43431 by gavage as described in methods section. The average numbers of apoptotic cells
(postive for caspase-3, panel A), neutrophilic granulocytes (neutrophils, positive for MPO-7, panel B), T-lymphocytes (positive for CD3, panel C), Tregs
(positive for FOXP3, panel D), and B-lymphocytes (positive for B220, panel E) from at least six high power fields (HPF, 4006magnification) per animal
were determined microscopically in immunohistochemically stained colon sections of naı ¨ve (Naı ¨ve, open symbols) and infected (+C. jejuni ATCC
43431, filled symbols) mfa (circles) and hfa (squares) mice at day 12 p.i.. Numbers of analyzed animals are given in parentheses. Medians (black bars)
and levels of significance (P-values) as compared to the indicated groups (determined by Student’s t-test) are indicated. Data shown are
representative for three independent experiments.
doi:10.1371/journal.pone.0020953.g005
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colonized isolator-raised germfree mice [13–15] pointed towards
an essential role of the conventional gut microbiota in the
colonization resistance against C. jejuni. The results presented here
do further underline the impact of the murine microbiota in
colonization resistance as was independently confirmed by
effective C. jejuni-infection of gnotobiotic, but not mfa mice. In
comparison with isolator-raised germfree mice, we favor our
animal model for the following reasons: First, gnotobiotic mice
generated by antibiotic treatment exhibit a physiologically
developed immune system. Second, these mice can be generated
under standardized breeding conditions in a sterile environment
within a common animal facility and without the need for special
equipment (such as isolators for instance) and, thus, costs for
generating and housing are significantly lower.
An experimental model of a human pathogen in mice
previously depleted of their intestinal gut microbiota and
subsequently replenished with human gut flora allows the study
of host-pathogen interactions in the natural host environment.
Given that these ‘‘humanized’’ mice, but not mice with a murine
flora, are susceptible to C. jejuni-infection indicates for the first
time, that the host-specific microflora composition is essential for
susceptibility or resistance to Campylobacter-infections resembling
the natural host conditions. However, individual bacterial species
or the complex microflora composition responsible for coloniza-
tion resistance have not been identified so far and await further
detailed investigation.
The susceptibility of gnotobiotic and hfa mice to C. jejuni-
infection renders the novel models presented here excellently
suited for standardized and reproducible analyses of C. jejuni
colonization and immunopathology in a higher vertebrate
experimental system. Most importantly, the inflammatory re-
sponses in the colon of C. jejuni-infected ‘‘humanized’’ mice in situ
mimicked key features of immunopathological responses in human
campylobacteriosis [4,5]: First, tissue damage was most pro-
nounced in the lower intestinal tract as indicated by increased
numbers of apoptotic cells in the colon mucosa. Second, C. jejuni-
induced mucosal injury was accompanied by an increased
recruitment of innate immune and effector cells (e.g. T- and B-
lymphocytes, Tregs and neutrophils) in the colon mucosa of
infected mice. Lastly, an increased secretion of pro-inflammatory
cytokines such as TNF-a, IL-6, and MCP-1 were found in ex vivo
colon cultures taken from infected hfa mice. Interestingly, Treg
numbers increased in the colons of hfa mice during the course of
C. jejuni-infection suggesting that production of IL-10 and other
anti-inflammatory mediators might be involved in limiting C. jejuni-
induced immunopathology. This was further supported by Bell
and coworkers (2009) who showed that C. jejuni is able to induce a
strong inflammatory response in IL-10 deficient mice [27].
Using our gnotobiotic infection model we could further dissect
the interplay between C. jejuni and the host innate responses.
Infection of gnotobiotic mice deficient in MyD88, TRIF or TLR4
revealed for the first time in vivo that MyD88- and TRIF-
dependent TLR4-recognition of bacterial LPS is essentially
involved in the development of immunopathology during C. jejuni
enteritis as indicated by lower numbers of apoptotic cells,
neutrophils, T- and B-lymphocytes as well as Tregs found in the
colon mucosa of the respective gene-deficient mice at day 12 p.i..
Similarly, other in vitro studies have shown the important role of
TLR4-signaling in C. jejuni LPS infected cells [22] and activation of
human TLR4 by C. jejuni [21].
Strikingly, our results obtained from infected TLR9-deficient
mice for the first time point towards a pivotal role of bacterial
CpG-DNA in mediating C. jejuni-induced immunopathology. The
activation of innate immune cells via TLR9, however, depends on
the cell type, and on both, the methylation status and sequence of
the DNA ligand under study [39]. Furthermore, a selected set of
Campylobacter strains did not activate human TLR9 expressed in a
transfected human cancer cell line [21]. However, this does not
rule out a role for TLR9 in human campylobacteriosis. The C.
jejuni population is genetically highly variable and could present
DNA of diverging sequence or methylation status to host immune
cells in a strain dependent manner. The C. jejuni strains used for
analysis of campylobacteriosis in mice presented here were neither
studied for TLR9 activation in human nor murine cell lines before.
Thus, the fact that C. jejuni-infected gnotobiotic mice lacking
TLR9 displayed less severe immunopathology points towards an
important role of TLR9 in the murine model. The role of TLR9 in
human C. jejuni-infection awaits further confirmation by additional
studies with cells of the adaptive and innate immune system.
Also noteworthy is the contribution of bacterial DNA and
TLR9 signaling in augmenting murine intestinal inflammation
Figure 6. Pro-inflammatory cytokine responses in the colon of C. jejuni-infected ‘‘humanized’’ mice. Mfa and hfa mice were generated
and orally infected with C. jejuni strain ATCC 43431 as described (see methods). Secretion of (A) TNF-a,( B) IL-6 and (C) MCP-1 was determined in
supernatants of ex vivo colon cultures from naı ¨ve animals (Naı ¨ve, open symbols) or infected (+C. jejuni ATCC 43431, filled symbols) mfa (circles) or hfa
(squares) mice at day 12 p.i.. Numbers of analyzed animals are given in parentheses. Means (black bars) and levels of significance (P-values) as
compared to the indicated groups (determined by Student’s t-test) are indicated. Data shown were pooled from two (for naı ¨ve mice) or three (for
infected animals) independent experiments.
doi:10.1371/journal.pone.0020953.g006
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versus-host disease we observed recently that TLR9 is essentially
involved in aggravation of colitis [40].
Finally, the murine C. jejuni-infection models presented here are
valuable tools to investigate C. jejuni virulence factors in vivo. Hfa
mice infected with C. jejuni mutant strains deficient in formic acid
metabolism or perception involved in cell invasion fitness harbored
comparable bacterial loads throughout the GI tract. However,
both mutant strains significantly displayed less immunopatholog-
ical responses as indicated by lower numbers of apoptotic cells,
neutrophils, T-lymphocytes, and Tregs in the colon mucosa as
compared to mice infected with the parental strain. This
diminished cellular response was paralleled by lower expression
of pro-inflammatory cytokines (IL-6, nitric oxide, and IFN-c) and
less translocation of living C. jejuni into MLNs in animals infected
with the B2DfdhD or B2Dcj0952c strain as compared to mice
infected with the wildtype strain. Given that these results underline
the suitability of the animal model presented here for in vivo
analyses of C. jejuni gene mutant strains, there is a possibility of
polar effects on downstream genes which cannot be ruled out.
Thus, the relevance of the fdhD or the cj0952c gene mutation for
amelioration of immunopathology and translocation following oral
infection cannot unequivocally be attributed to the gene products
encoded by the deleted genes. Nevertheless, since formic acid is a
metabolite produced by many commensal gut bacteria and thus
part of the intestinal intraluminal milieu, these findings point
towards an essential role of formic acid metabolism and perception
in the intestinal ‘‘lifestyle’’ of C. jejuni and its cell invasiveness in vivo.
Taken together, we conclude that our novel murine models for
colonization and inflammation following C. jejuni-infection shown
in the present study, mimic many important aspects of human C.
jejuni-infection and thus offer promising novel tools to better
understand the arousing ‘‘me ´nage a ` trois’’ between the pathogen,
commensal gut bacteria, and host innate immune responses.
Materials and Methods
Ethics Statement
All animal experiments were conducted according to the
European Guidelines for animal welfare (2010/63/EU) with
Figure 7. Impact of C. jejuni formic acid metabolism and perception on immunopathology in ‘‘humanized’’ mice. Hfa mice were
generated as described (see methods) and orally infected with the C. jejuni wildtype strain (B2 WT), or with isogenic mutants deficient in the formate
dehydrogenase subunit D (B2DfdhD) or the formic acid receptor (B2Dcj0952c). The average numbers of apoptotic cells (positive for Caspase-3, panel
A), neutrophilic granulocytes (neutrophils, positive for MPO-7, panel B), T-lymphocytes (positive for CD3, panel C), regulatory T-cells (Treg, positive
for FOXP3, panel D) and B-lymphocytes (positive for B220, panel E) from at least six high power fields (HPF, 4006magnification) per animal were
determined microscopically in immunohistochemically stained colon sections of naı ¨ve, non-infected (None, open circles) and infected (B2 WT: filled
circles; B2DfdhD: grey circles; B2Dcj0952c: crossed circles) mice at d12 post infection. Numbers of analyzed animals are given in parentheses. Means
(black bars) and levels of significance (P-values) as compared to the respective groups (determined by Student’s t-test) are indicated. Data shown are
representative for three independent experiments.
doi:10.1371/journal.pone.0020953.g007
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‘‘Landesamt fu ¨r Gesundheit und Soziales’’ (LaGeSo, Berlin,
Germany; registration number TVV G0173/07). Animal welfare
was monitored twice daily by assessment of clinical conditions.
Fresh human fecal samples for recolonizing gnotobiotic mice (hfa)
were collected from healthy volunteers. Before sample collection
written informed consent was obtained from all volunteers. Since
fecal samples were obtained from co-workers of our laboratory
and thus outside a clinical environment and used for re-
colonization of mice only, experiments were exempted from
approval by the Charite ´ - Universita ¨tsmedizin ethical committee
according to German legacy (115, Legal Basis for Clinical Trials).
Mice
All animals were maintained in the facilities of the ‘‘Forschungs-
institut fu ¨r Experimentelle Medizin’’ (FEM, Charite ´ - Universi-
ta ¨tsmedizin, Berlin, Germany), under specific pathogen-free (SPF)
conditions. Mice deficient in TLR4 (C57BL/10ScSn (C10)
background), TLR9, TRIF or MyD88 (C57BL/6 (C6) back-
ground), used in the experiments are described in detail elsewhere
[40]. Age and sex matched mice between 10 and 12 weeks of age
were used.
Generation of gnotobiotic mice
To eradicate the commensal gut flora, mice were transferred to
sterile cages and treated by adding ampicillin (1 g/L; Ratio-
pharm), vancomycin (500 mg/L; Cell Pharm), ciprofloxacin
(200 mg/L; Bayer Vital), imipenem (250 mg/L; MSD), and
metronidazole (1 g/L; Fresenius) to the drinking water ad libitum
for 6–8 weeks as described earlier [30].
Generation of gnotobiotic mice with a human or murine
gut flora
Fresh human and murine fecal samples free of enteropathogenic
bacteria, parasites, and viruses were collected from five individual
healthy volunteers and animals, respectively, pooled and dissolved
in an equal volume of sterile PBS, aliquoted and stored at 280uC
until use. For reconstitution experiments, aliquots were thawed
and bacterial communities quantified by cultural and molecular
methods (refer to [30]) before gavage of mice with 0.3 mL of the
respective suspension. Between independent experiments bacterial
counts of groups varied of less than 0.5 log orders of magnitude.
C. jejuni-infection of mice
Conventional, gnotobiotic or mice reconstituted with human or
murine gut flora were infected with 10
9 viable CFU of C. jejuni
strains ATCC 43431, 81–176, B2 or mutant strains B2DfdhD and
B2Dcj0952c deficient in the formate dehydrogenase subunit D or
the formic acid receptor gene, respectively [37], by gavage in a
total volume of 0.3 mL PBS on three consecutive days.
Sampling procedures and histopathology
Mice were sacrificed by isofluran treatment (Abbott, Germany).
Cardiac blood and tissue samples from liver, spleen, kidneys,
MLNs, and gastrointestinal (GI) tract (stomach, duodenum, ileum,
colon) were removed under sterile conditions. GI samples from
each mouse were collected in parallel for histological, microbio-
logical, immunological, and molecular analyses. Histopathological
changes were determined in colon samples immediately fixed in
5% formalin and embedded in paraffin. Sections (5 mm) were
stained with hematoxylin and eosion (HE) and examined by light
microscopy (magnification 6200).
Immunohistochemistry
In situ immunohistochemical analysis of colon paraffin sections
was performed as described previously [40]. Primary antibodies
against CD3 (#N1580, Dako, Denmark, dilution 1:10), myelo-
peroxidase-7 (MPO-7, # A0398, Dako, 1:10000), FOXP-3 (FJK-
16s, eBioscience, 1:100), B220 (eBioscience, San Diego, CA, USA,
1:200), and cleaved caspase-3 (Asp175, Cell Signaling, USA,
1:200) were used. For each animal, the average number of
positively stained cells within at least six high power fields (HPF,
4006 magnification) were determined microscopically by three
independent investigators (MMH, RP, AAK).
Quantitative analysis of C. jejuni translocation
Live C. jejuni were detected in MLNs, spleen, liver, kidneys, and
cardiac blood by culture. Tissues were homogenized in sterile PBS
Figure 8. Impact of C. jejuni formic acid metabolism and perception on cytokine responses in ‘‘humanized’’ mice. Hfa mice were
generated as described (see methods) and orally infected with the C. jejuni wildtype strain (B2 WT), or with isogenic mutants deficient in the formate
dehydrogenase subunit D (B2DfdhD) or the formic acid receptor (B2Dcj0952c). Secretion of (A) IL-6, (B) NO and (C) IFN-c was determined in
supernatants of ex vivo colon cultures obtained from infected (B2 WT: filled circles; B2DfdhD: grey circles; B2Dcj0952c: crossed circles) mice at d12 p.i..
Numbers of analyzed animals are given in parentheses. Means (black bars) and levels of significance (P-values) as compared to the respective groups
(determined by Student’s t-test) are indicated. Data shown are representative for three independent experiments.
doi:10.1371/journal.pone.0020953.g008
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Germany) in a microaerophilic atmosphere at 37uC for at least
48 hours. Cardiac blood (0.2 mL) was immediately streaked out
on karmali agar plates.
Analysis of the intestinal microflora
Cultural analyses, biochemical identification, and molecular
detection of luminal bacterial communities from stomach, duode-
num, ileum, and colon were performed as previously described
[30,31,41]. Genetic fingerprints of the intestinal microflora were
generated by PCR-based denaturing-gradient-gel-electrophoresis
(PCR-DGGE) amplifying the 16S rRNA variable region V6–8
[30]. Quantitative real-time PCR (qRT-PCR) was performed on a
StepOnePlus RealTime-PCR System (Applied Biosystems) using the
Maxima SYBR Green/ROX qPCR Master Mix (Fermentas). The
reaction volume was 20 mlu s i n g2ml template DNA at following
cycling conditions (40 cycles): Initial denaturation / enzyme
activation at 95uC for 10 min, initial denaturation at 95uC for 15 s
followed by annealing / elongation at 60uC for 1 min. Fluorescence
detection was performed at 80uC( 7 5 uCf o rB P / M I B ;7 0 uCf o rE C )
aftereachcycle.Ameltingcurveforeachrunwasperformedtocheck
for the correct amplicon. Total bacteria (TL), gamma-Proteobacteria /
Enterobacteriaceae (EB), Lactobacillus group (LB), Clostridium leptum group
(CL), Clostridium coccoides group (CC), Bacteroides group including
Prevotella and Porphyromonas (BP), Mouse Intestinal Bacteroidetes (MIB),
Enterococci (EC) and Bifidobacteria (BB) were separately detected and
Figure 9. Impact of C. jejuni formic acid metabolism and perception on bacterial translocation to mesenteric lymphnodes.
Gnotobiotic (GNOTO; circles) and with human flora associated (HFA; squares) mice were generated as described (see methods). Conventionally
colonized (MFA; diamonds) animals served as negative controls. Mice were orally infected with the C. jejuni wildtype strain (B2 WT; solid symbols), or
with isogenic mutants deficient in the formate dehydrogenase subunit D (B2DfdhD; grey symbols) or the formic acid receptor (B2Dcj0952c; crossed
symbols). At d12 post infection, live C. jejuni were quantified in homogenized MLNs by culture (as described in methods; CFU, colony forming units).
Medians (black bars) and significance levels (P-values) determined by Mann-Whitney-U test are indicated. Absolute and relative numbers of animals
harboring C. jejuni are given in parentheses. Data shown are pooled from three independent experiments.
doi:10.1371/journal.pone.0020953.g009
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loads of feces samples and luminal GI contents were determined with
a flagellin A based qRT-PCR (flaA AW 50 fw, 59-ATGG-
GATTTCGTATTAACAC-39, flaA AW 5 re 59-GATATAGCTT-
GACCTAAAGTA-39) resulting in a 197bp product (primers taken
from: Dr. K. Pietsch, Freiburg, personal communication). The
Campylobacter-flaA-PCR cycling conditions were different to the above
mentioned: Annealing was at 55uC for 20 s, elongation at 60uCf o r
30 s and fluorescence detection at 70uC. In general,the 16S rRNA or
flaA gene numbers / ng DNA of each sample were determined, not
the actual bacterial numbers.
Cytokine detection in colon culture supernatants
Colon biopsies were cut longitudinally, washed in PBS, and
strips of 1 cm
2 were placed in 24-flat-bottom well culture plates
(Nunc, Wiesbaden, Germany) containing 500 ml serum-free RPMI
1640 medium supplemented with penicillin (100 U/ ml) and
streptomycin (100 ug/ ml; PAA Laboratories). After 18 h at 37uC,
culture supernatants were tested for TNF-a, IL-6, MCP-1, and
IFN-c by the Mouse Inflammation Cytometric Bead Assay (CBA;
BD Biosciences) on a BD FACSCanto II flow cytometer (BD
Biosciences). Nitric oxide (NO) was determined by Griess-reaction
as described earlier [30].
Statistical analysis
Mean values, medians, standard deviations, and levels of
significance were determined using appropriate tests as indicated
(two-tailed Student’s t-Test, Mann-Whitney-U Test). Two-sided
probability (P ) values#0.05 were considered significant. All
experiments were repeated at least twice.
Supporting Information
Figure S1 PCR-based detection of gut bacteria in feces
from conventionally colonized, but not gnotobiotic mice.
PCR analysis with eubacterial primer amplifying 16S V6–8 region
of DNA from fecal samples obtained from nine conventionally
raised mice (conventional) and gnotobiotic mice (gnotobiotic) were
performed and run on 1% agarose gels stained with ethidium-
bromide.
(TIF)
Figure S2 C. jejuni colonization in gnotobiotic and
conventional mice. Conventional wildtype mice (SPF, open
circles), and gnotobiotic mice (GNOTO, filled circles, generated by
antibiotic gut decontamination) were orally infected with C. jejuni
strains 81–176, ATCC 43431 or B2 (as indicated on the x-axis) as
described (see methods). The colonization capacity was determined
by quantification of live C. jejuni in feces samples at day 12 p.i. by
cultural analysis (CFU, colony forming units). Numbers of animals
harboring C. jejuni out of the total number of analyzed animals are
given in parentheses. Medians (black bars) and significance levels (P-
values, as compared to SPF animals) determined by Mann-Whitney-
U test are indicated. Data shown were pooled from three
independent experiments.
(TIF)
Figure S3 Histopathology in colon sections following C.
jejuni infection. Paraffin sections of colon samples were HE-
stained as described (see methods). (A) In naı ¨ve, uninfected
wildtype mice many goblet cells (dashed arrows), normal crypt
architecture, and no immune cell infiltration were observed. (B)
TLR4-deficient mice displayed mild immune cell infiltration (solid
arrow), whereas in wildtype animals (C) loss of goblet cells (dashed
arrows), crypt elongation, and moderate immune cell infiltration
into the lamina propria (solid arrow) could be detected at day 12
following C. jejuni ATCC 43431-infection. Representative photo-
micrographs (magnification 6200) from three independent
experiments are shown.
(TIF)
Figure S4 Quantitative molecular analysis of fecel
samples obtained from mfa and hfa mice. (A) Quantitative
Real-Time-PCR amplifying bacterial 16S rRNA variable regions.
16S rRNA gene numbers / ng DNA from luminal colon content
of mfa (M, open squares) or hfa (H, filled squares) recolonized mice
after C. jejuni-infection (day 42 p.i.) of the following bacterial
groups were determined: Enterobacteriaceae (EB), enterococci (EC),
lactic acid Bacteria (LB), Bacteroides/ Prevotella spp. (BP), Clostridium
leptum group (CL), Clostridium coccoides group (CC), mouse intestinal
bacteroidetes (MIB), Bifidobacteria (BB), and total eubacterial load
(TL). Medians (black bars) and significance levels (P-values)
determined by Mann-Whitney-U test are indicated. Quantitative
loads of the respective bacterial groups at day 0 (after stable re-
colonization; circles) and at day 42 (d42, squares) after C. jejuni-
infection obtained from MFA (B; open symbols) and HFA (C;
filled symbols) mice were analyzed by qRT-PCR. Numbers of
animals harboring the respective bacterial rRNA are given in
parentheses. Medians are indicated as black bars. Data shown
were pooled from three independent experiments.
(TIF)
Figure S5 Impact of C. jejuni formic acid metabolism
and perception on colonization in ‘‘humanized’’ mice.
Human flora associated mice (hfa) were generated as described
(see methods) and orally infected with the C. jejuni wildtype (WT;
A) strain B2, or with isogenic mutants deficient in the formate
dehydrogenase subunit D (B2DfdhD; B) or the formic acid receptor
(B2Dcj0952c; C). The kinetic analysis of colonization capacity was
determined by quantification of live C. jejuni in luminal colon
samples until day 12 post infection by culture (CFU, colony
forming units). Medians (black bars) and days post infection (on x-
axis) are indicated. Numbers of animals harboring C. jejuni out of
the total number of analyzed animals are given in parentheses.
Data shown were pooled from three independent experiments.
(TIF)
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